SynthMol:一种药物安全预测框架,将图形注意力和分子描述器集成到预训练的几何模型中
Zidong Su1, Rong Zhang1, Xiaoyu Fan1
1MOE Key Laboratory of Bioinformatics, State Key Laboratory of Molecular Oncology, Beijing Frontier Research Center for Biological Structure, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.
Journal of chemical information and modeling
|February 25, 2025
概括
深度学习框架SynthMol通过整合3D结构特征和图形注意力网络来增强药物安全预测. 这种先进的分子性质预测工具可以提高药物开发中关键安全性评估的准确性.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 在药理学中的机器学习.
背景情况:
- 药物安全对于临床成功至关重要,受各种分子性质的影响.
- 准确的安全评估对于评估候选药物至关重要.
- 在生物活性数据上训练的机器学习模型为药物安全性评估提供了一个有希望的途径.
研究的目的:
- 介绍SynthMol,这是一个用于分子性质预测的新型深度学习框架.
- 用先进的计算方法提高药物安全性评估的准确性.
- 为了验证SynthMol在既定和现实世界的药物安全数据集上的表现.
主要方法:
- SynthMol集成了预先训练的3D结构特征,图表注意力网络和分子指纹.
- 该框架在22个不同的数据集上进行了评估,包括MoleculeNet,MolData和药物安全数据.
- 性能与用于分子性质预测的最先进模型进行了基准测试.
主要成果:
- 与现有模型相比,SynthMol在大多数评估任务中显示出更高的预测准确性.
- 在BBBP数据集上获得0.944的ROC-AUC (2.61%的改善),在hERG数据集上达到0.906 (2.38%的改善).
- 与实验hERG毒性和CYP抑制数据的验证证实了SynthMol在区分与药物开发相关的功能变化的有用性.
结论:
- SynthMol在药物安全性评估的深度学习中取得了重大进展.
- 该框架能够准确预测分子特性,这有助于识别更安全的候选药物.
- 通过改善早期安全性评估,SynthMol为加速药物开发提供了宝贵的工具.
相关概念视频
Molecular Models
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
Predicting Molecular Geometry
VSEPR Theory for Determination of Electron Pair Geometries
Synthetic Biology
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...


